We are live on
!
Find out more
BC
Broadwood Capital Portfolio holdings
AUM
$1.91B
1-Year Est. Return
44.39%
This Fund
S&P 500
This Quarter
Est. Return
+37.58%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$440M
AUM Growth
–
Cap. Flow
+$319M
Cap. Flow
% of AUM
72.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$117M |
| 2 |
Monster Beverage
MNST
|
+$92.3M |
| 3 |
STAAR Surgical
STAA
|
+$51.8M |
| 4 |
Lineage Cell Therapeutics
LCTX
|
+$35.8M |
| 5 |
CYNO
Cynosure, Inc. Class A
CYNO
|
+$20.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.62% |
| 2 | Healthcare | 27.72% |
| 3 | Consumer Staples | 22.67% |
Similar funds
EWS
RMA
LWMT
FIB
SAM
HPC
R
CCIA
Broadwood Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Broadwood Capital, which disclosed 7 positions worth $440M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is QUESTCOR PHARMA INC: 3,296,660 shares worth $150M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, followed by Healthcare and Consumer Staples.
- Broadwood Capital's largest Q2 2013 buy was QUESTCOR PHARMA INC: 3,296,660 shares worth $150M.
- Broadwood Capital's ten largest holdings make up 100% of its $440M portfolio in Q2 2013.
- Broadwood Capital disclosed 7 positions in Q2 2013, its first 13F filing on record.
Based on Broadwood Capital's 13F filing for Q2 2013, filed 14 Aug 2013.